Screener
Vir Biotechnology, Inc. VIR Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $238.95M+19,583% | -$29K-101% | $64.07M+418% | $240K-89.9% | $1.21M-60.5% | ||
| $0-100% | —— | —— | —— | $11K-78.8% | ||
| $238.95M+19,763% | —— | —— | —— | $1.2M-60.2% | ||
| 100%+0.9pp | —— | —— | —— | 99.1%+0.8pp | ||
| $135.28M+38.7% | $108.92M-8.2% | $88.35M-16.7% | $151.46M-22.4% | $97.51M-7.2% | ||
| $30.2M+35.5% | $23.34M-2.5% | $23.62M-11.6% | $22.23M-13.6% | $22.28M-26.4% | ||
| $165.48M+38.3% | $132.26M-7.2% | $111.99M-13.5% | $173.68M-25.7% | $119.63M-26.0% | ||
| $73.47M+162% | -$132.29M+5.2% | -$47.92M+59.1% | -$173.44M+25.0% | -$118.42M+25.4% | ||
| 30.7%+9,785pp | 456,172.4%+460,775pp | -74.8%+872pp | -72,267.9%-62,549pp | -9,754.3%-4,596pp | ||
| $6.79M-11.0% | $6.77M-63.6% | $4.86M-61.0% | $10.47M-41.1% | $7.63M-59.3% | ||
| $80.26M+172% | -$125.53M-3.8% | -$43.06M+58.9% | -$162.97M+23.7% | -$110.79M+20.8% | ||
| $179K+5.3% | $170K+963% | —— | $168K-5.1% | $170K+111% | ||
| $80.08M+172% | -$125.7M-3.9% | -$42.92M+59.0% | -$163.14M+23.7% | -$110.96M+19.8% | ||
| 33.5%+9,173pp | 433,431%+437,421pp | -67%+778pp | -67,975.4%-58,996pp | -9,139.9%-4,640pp | ||
| $0.47+159% | -$0.85+3.4% | -$0.30+60.5% | -$1.17+25.0% | -$0.80+21.6% | ||
| $76.27M+166% | -$129.48M+5.3% | -$45.02M+60.6% | -$170.45M+25.4% | -$115.5M+25.2% | ||
| 31.9%+9,546pp | 446,479.3%+450,987pp | -70.3%+853pp | -71,018.8%-61,422pp | -9,514%-4,494pp | ||
| $73.47M+162% | -$132.29M+5.2% | -$47.92M+59.1% | -$173.44M+25.0% | -$118.42M+25.4% |
FAQ
- What is Vir Biotechnology, Inc.'s revenue?
- Vir Biotechnology, Inc. (VIR) generated $303.2M in revenue over the trailing twelve months, up 1495.9% year over year.
- Is Vir Biotechnology, Inc. profitable?
- Vir Biotechnology, Inc. is not currently profitable: it reported a net loss of $251.7M over the trailing twelve months, a -83.0% net margin.
- What are Vir Biotechnology, Inc.'s profit margins?
- Gross margin is 96.1% and operating margin is -92.4%, with a -83.0% net margin.
- What is Vir Biotechnology, Inc.'s earnings per share?
- Vir Biotechnology, Inc.'s diluted EPS over the trailing twelve months is $-1.85.
- Where does Vir Biotechnology, Inc.'s income statement data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
